1 Market Overview of Recombinant Protein Therapeutics |
|
1.1 Recombinant Protein Therapeutiarket Overview |
|
| 1.1.1 Recombinant Protein Therapeutics Product Scope | |
| 1.1.2 Market Status and Outlook | |
1.2 Global Recombinant Protein Therapeutiarket Size Overview by Region 2015 VS 2020 VS 2026 |
|
1.3 Global Recombinant Protein Therapeutiarket Size by Region (2015-2026) |
|
1.4 Global Recombinant Protein Therapeutics Historic Market Size by Region (2015-2020) |
|
1.5 Global Recombinant Protein Therapeutiarket Size Forecast by Region (2021-2026) |
|
1.6 Key Regions, Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) |
|
| 1.6.1 North America Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.2 Europe Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.3 Asia-Pacific Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.4 Latin America Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) | |
| 1.6.5 Middle East & Africa Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) | |
2 Recombinant Protein Therapeutiarket Overview by Type |
|
2.1 Global Recombinant Protein Therapeutiarket Size by Type: 2015 VS 2020 VS 2026 |
|
2.2 Global Recombinant Protein Therapeutics Historic Market Size by Type (2015-2020) |
|
2.3 Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2021-2026) |
|
2.4 Recombinant Hormones |
|
2.5 Interferons |
|
2.6 Interleukins |
|
2.7 Hematopoietic Growth Factors |
|
2.8 Others |
|
3 Recombinant Protein Therapeutiarket Overview by Application |
|
3.1 Global Recombinant Protein Therapeutiarket Size by Application: 2015 VS 2020 VS 2026 |
|
3.2 Global Recombinant Protein Therapeutics Historic Market Size by Application (2015-2020) |
|
3.3 Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2021-2026) |
|
3.4 Diabetes |
|
3.5 Dwarfism |
|
| 詳^情：http://www.5269660.cn/6/78/Global-Recombinant-Protein-Therapeutics-Industry-Analysis-and-Trends-Report-2020-2026.html | |
3.6 Heart Disease |
|
3.7 Cancer |
|
3.8 Others |
|
4 Global Recombinant Protein Therapeutics Competition Analysis by Players |
|
4.1 Global Recombinant Protein Therapeutiarket Size by Players (2015-2020) |
|
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Therapeutics as of 2019) |
|
4.3 Date of Key Manufacturers Enter into Recombinant Protein Therapeutiarket |
|
4.4 Global Top Players Recombinant Protein Therapeutics Headquarters and Area Served |
|
4.5 Key Players Recombinant Protein Therapeutics Product Solution and Service |
|
4.6 Competitive Status |
|
| 4.6.1 Recombinant Protein Therapeutiarket Concentration Rate | |
| 4.6.2 Mergers & Acquisitions, Expansion Plans | |
5 Company (Top Players) Profiles and Key Data |
|
5.1 Company 1 |
|
| 5.1.1 Company 1 Profile | |
| 5.1.2 Company 1 Main Business | |
| 5.1.3 Company 1 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.1.4 Company 1 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.1.5 Company 1 Recent Developments | |
5.2 Company 2 |
|
| 5.2.1 Company 2 Profile | |
| 5.2.2 Company 2 Main Business | |
| 5.2.3 Company 2 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.2.4 Company 2 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.2.5 Company 2 Recent Developments | |
5.3 Company 3 |
|
| 5.5.1 Company 3 Profile | |
| 5.3.2 Company 3 Main Business | |
| 5.3.3 Company 3 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.3.4 Company 3 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.3.5 Company 4 Recent Developments | |
5.4 Company 4 |
|
| 5.4.1 Company 4 Profile | |
| 5.4.2 Company 4 Main Business | |
| 5.4.3 Company 4 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.4.4 Company 4 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.4.5 Company 4 Recent Developments | |
5.5 Company 5 |
|
| 5.5.1 Company 5 Profile | |
| 5.5.2 Company 5 Main Business | |
| 5.5.3 Company 5 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.5.4 Company 5 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.5.5 Company 5 Recent Developments | |
5.6 Company 6 |
|
| 5.6.1 Company 6 Profile | |
| 5.6.2 Company 6 Main Business | |
| 5.6.3 Company 6 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.6.4 Company 6 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.6.5 Company 6 Recent Developments | |
5.7 Company 7 |
|
| 5.7.1 Company 7 Profile | |
| 5.7.2 Company 7 Main Business | |
| 5.7.3 Company 7 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.7.4 Company 7 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.7.5 Company 7 Recent Developments | |
5.8 Company 8 |
|
| 5.8.1 Company 8 Profile | |
| 5.8.2 Company 8 Main Business | |
| 全球重組蛋白治療行業分析與趨勢報告2020-2026 | |
| 5.8.3 Company 8 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.8.4 Company 8 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.8.5 Company 8 Recent Developments | |
5.9 Company 9 |
|
| 5.9.1 Company 9 Profile | |
| 5.9.2 Company 9 Main Business | |
| 5.9.3 Company 9 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.9.4 Company 9 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.9.5 Company 9 Recent Developments | |
5.10 Company 10 |
|
| 5.10.1 Company 10 Profile | |
| 5.10.2 Company 10 Main Business | |
| 5.10.3 Company 10 Recombinant Protein Therapeutics Products, Services and Solutions | |
| 5.10.4 Company 10 Recombinant Protein Therapeutics Revenue (US$ Million) & (2015-2020) | |
| 5.10.5 Company 10 Recent Developments | |
6 North America |
|
6.1 North America Recombinant Protein Therapeutiarket Size by Country |
|
6.2 United States |
|
6.3 Canada |
|
7 Europe |
|
7.1 Europe Recombinant Protein Therapeutiarket Size by Country |
|
7.2 Germany |
|
7.3 France |
|
7.4 U.K. |
|
7.5 Italy |
|
7.6 Russia |
|
7.7 Nordic |
|
7.8 Rest of Europe |
|
8 Asia-Pacific |
|
8.1 Asia-Pacific Recombinant Protein Therapeutiarket Size by Region |
|
8.2 China |
|
8.3 Japan |
|
8.4 South Korea |
|
8.5 Southeast Asia |
|
8.6 India |
|
8.7 Australia |
|
8.8 Rest of Asia-Pacific |
|
9 Latin America |
|
9.1 Latin America Recombinant Protein Therapeutiarket Size by Country |
|
9.2 Mexico |
|
9.3 Brazil |
|
9.4 Rest of Latin America |
|
10 Middle East & Africa |
|
10.1 Middle East & Africa Recombinant Protein Therapeutiarket Size by Country |
|
10.2 Turkey |
|
10.3 Saudi Arabia |
|
10.4 UAE |
|
10.5 Rest of Middle East & Africa |
|
11 Recombinant Protein Therapeutiarket Dynamics |
|
11.1 Industry Trends |
|
11.2 Market Drivers |
|
11.3 Market Challenges |
|
11.4 Market Restraints |
|
12 Research Finding /Conclusion |
|
13 Methodology and Data Source |
|
13.1 Methodology/Research Approach |
|
| 13.1.1 Research Programs/Design | |
| 13.1.2 Market Size Estimation | |
| 全球重組蛋白治療行業分析與趨勢報告2020-2026 | |
| 13.1.3 Market Breakdown and Data Triangulation | |
13.2 Data Source |
|
| 13.2.1 Secondary Sources | |
| 13.2.2 Primary Sources | |
13.3 Disclaimer |
|
13.4 Author List |
|
| List of Tables | |
| Table 1. Global Market Recombinant Protein Therapeutiarket Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 | |
| Table 2. Global Recombinant Protein Therapeutiarket Size by Region (2015-2020) (US$ Million) | |
| Table 3. Global Recombinant Protein Therapeutiarket Size Share by Region (2015-2020) | |
| Table 4. Global Recombinant Protein Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) | |
| Table 5. Global Recombinant Protein Therapeutics Forecasted Market Size Share by Region (2021-2026) | |
| Table 6. Global Recombinant Protein Therapeutiarket Size (US$ Million) by Type: 2015 VS 2020 VS 2026 | |
| Table 7. Global Recombinant Protein Therapeutiarket Size by Type (2015-2020) (US$ Million) | |
| Table 8. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2015-2020) | |
| Table 9. Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) | |
| Table 10. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2021-2026) | |
| Table 11. Global Recombinant Protein Therapeutiarket Size (US$ Million) by Application: 2015 VS 2020 VS 2026 | |
| Table 12. Global Recombinant Protein Therapeutiarket Size by Application (2015-2020) (US$ Million) | |
| Table 13. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2015-2020) | |
| Table 14. Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) | |
| Table 15. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2021-2026) | |
| Table 16. Global Recombinant Protein Therapeutics Revenue (US$ Million) by Players (2015-2020) | |
| Table 17. Global Recombinant Protein Therapeutics Revenue Market Share by Players (2015-2020) | |
| Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Therapeutics as of 2019) | |
| Table 19. Date of Key Manufacturers Enter into Recombinant Protein Therapeutiarket | |
| Table 20. Global Recombinant Protein Therapeutics Top Players Headquarters and Area Served | |
| Table 21. Recombinant Protein Therapeutics Product Solution and Service | |
| Table 22. Global Recombinant Protein Therapeutianufacturers Market Concentration Ratio (CR5 and HHI) | |
| Table 23. Mergers & Acquisitions, Expansion Plans | |
| Table 24. Company 1 Basic Information List | |
| Table 25. Company 1 Description and Business Overview | |
| Table 26. Company 1 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 27. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 1 (2015-2020) | |
| Table 28. Company 1 Recent Developments | |
| Table 29. Company 2 Basic Information List | |
| Table 30. Company 2 Description and Business Overview | |
| Table 31. Company 2 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 32. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 2 (2015-2020) | |
| Table 33. Company 2 Recent Developments | |
| Table 34. Company 3 Basic Information List | |
| Table 35. Company 3 Description and Business Overview | |
| Table 36. Company 3 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 37. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 3 (2015-2020) | |
| Table 38. Company 3 Recent Developments | |
| Table 39. Company 4 Basic Information List | |
| Table 40. Company 4 Description and Business Overview | |
| Table 41. Company 4 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 42. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 4 (2015-2020) | |
| Table 43. Company 4 Recent Developments | |
| Table 44. Company 5 Basic Information List | |
| Table 45. Company 5 Description and Business Overview | |
| Table 46. Company 5 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 47. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 5 (2015-2020) | |
| Table 48. Company 5 Recent Developments | |
| Table 49. Company 6 Basic Information List | |
| Table 50. Company 6 Description and Business Overview | |
| Table 51. Company 6 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Quánqiú chóngzǔ dànbái zhìliáo hángyè fēnxī yǔ qūshì bàogào 2020-2026 | |
| Table 52. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 6 (2015-2020) | |
| Table 53. Company 6 Recent Developments | |
| Table 54. Company 7 Basic Information List | |
| Table 55. Company 7 Description and Business Overview | |
| Table 56. Company 7 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 57. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 7 (2015-2020) | |
| Table 58. Company 7 Recent Developments | |
| Table 59. Company 8 Basic Information List | |
| Table 60. Company 8 Description and Business Overview | |
| Table 61. Company 8 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 62. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 8 (2015-2020) | |
| Table 63. Company 8 Recent Developments | |
| Table 64. Company 9 Basic Information List | |
| Table 65. Company 9 Description and Business Overview | |
| Table 66. Company 9 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 67. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 9 (2015-2020) | |
| Table 68. Company 9 Recent Developments | |
| Table 69. Company 10 Basic Information List | |
| Table 70. Company 10 Description and Business Overview | |
| Table 71. Company 10 Recombinant Protein Therapeutics Products, Services and Solutions | |
| Table 72. Revenue (Million US$) in Recombinant Protein Therapeutics Business of Company 10 (2015-2020) | |
| Table 73. Company 10 Recent Developments | |
| Table 74. North America Recombinant Protein Therapeutiarket Size by Country (2015-2020) & (US$ Million) | |
| Table 75. North America Recombinant Protein Therapeutiarket Size Share by Country (2015-2020) | |
| Table 76. Europe Recombinant Protein Therapeutiarket Size by Country (2015-2020) & (US$ Million) | |
| Table 77. Europe Recombinant Protein Therapeutiarket Size Share by Country (2015-2020) | |
| Table 78. Asia-Pacific Recombinant Protein Therapeutiarket Size by Region (2015-2020) & (US$ Million) | |
| Table 79. Asia-Pacific Recombinant Protein Therapeutiarket Size Share by Region (2015-2020) (US$ Million) | |
| Table 80. Latin America Recombinant Protein Therapeutiarket Size by Country (2015-2020) & (US$ Million) | |
| Table 81. Latin America Recombinant Protein Therapeutiarket Size Share by Country (2015-2020) (US$ Million) | |
| Table 82. Middle East & Africa Recombinant Protein Therapeutiarket Size by Players (2015-2020) (US$ Million) | |
| Table 83. Middle East & Africa Recombinant Protein Therapeutiarket Size Share by Players (2015-2020) (US$ Million) | |
| Table 84. Recombinant Protein Therapeutiarket Trends | |
| Table 85. Recombinant Protein Therapeutiarket Drivers | |
| Table 86. Recombinant Protein Therapeutiarket Challenges | |
| Table 87. Recombinant Protein Therapeutiarket Restriants | |
| Table 88. Research Programs/Design for This Report | |
| Table 89. Key Data Information from Secondary Sources | |
| Table 90. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Global Recombinant Protein Therapeutiarket Size Year-over-Year 2015-2026 & (US$ Million) | |
| Figure 2. Global Recombinant Protein Therapeutiarket Size (US$ Million), 2015 VS 2020VS 2026 | |
| Figure 3. Global Recombinant Protein Therapeutiarket Share by Regions: 2020 VS 2026 | |
| Figure 4. North America Recombinant Protein Therapeutiarket Size (US$ Million) Growth Rate (2015-2026) | |
| Figure 5. Europe Recombinant Protein Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 6. Asia-Pacific Recombinant Protein Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 7. Latin America Recombinant Protein Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 8. Middle East & Africa Recombinant Protein Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 9. Global Recombinant Protein Therapeutiarket Share by Type in 2020 & 2026 | |
| Figure 10. Recombinant Hormones Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 11. Interferons Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 12. Interleukins Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 13. Hematopoietic Growth Factors Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 14. Others Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 15. Global Recombinant Protein Therapeutiarket Size Share by Application in 2020 & 2026 | |
| Figure 16. Diabetes Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 17. Dwarfism Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 18. Heart Disease Market Size (US$ Million) YoY Growth (2015-2026) | |
| 世界的な組換えタンパク質治療薬業界分析とトレンドレポート2020-2026 | |
| Figure 19. Cancer Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 20. Others Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 21. Recombinant Protein Therapeutiarket Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 | |
| Figure 22. Global Top 5 and Top 10 Players Recombinant Protein Therapeutiarket Share in 2019 | |
| Figure 23. United States Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 24. Canada Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 25. Germany Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 26. France Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 27. U.K. Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 28. Italy Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 29. Russia Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 30. Nordic Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 31. Rest of Europe Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 32. China Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 33. Japan Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 34. South Korea Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 35. Southeast Asia Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 36. India Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 37. Australia Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 38. Rest of Asia-Pacific Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 39. Mexico Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 40. Brazil Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 41. Rest of Latin America Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 42. Turkey Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 43. Saudi Arabia Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 44. UAE Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 45. Rest of Middle East & Africa Recombinant Protein Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 46. Bottom-up and Top-down Approaches for This Report | |
| Figure 47. Data Triangulation | |
略……
如需購買《Global Recombinant Protein Therapeutics Industry Analysis and Trends Report 2020-2026》，編號：2956786
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號